Helicobacter pylori: Does it add to risk of coronary artery disease

Area of Science:

• Microbiology and Immunology
• Cardiovascular Disease Research

Background:

• Helicobacter pylori (H. pylori) is a gram-negative bacterium recognized as a pathogen causing gastritis, peptic ulcers, and gastric cancers.
• Emerging research suggests H. pylori may contribute to extra-gastric conditions like immune thrombocytopenia and iron deficiency anemia.
• The potential role of H. pylori in atherosclerosis and coronary artery disease (CAD) pathogenesis, possibly through chronic inflammation, is under investigation.

Purpose of the Study:

• To critically evaluate the existing scientific evidence linking Helicobacter pylori infection to the development of coronary artery disease (CAD).
• To determine if the association between H. pylori and CAD is definitively established.
• To explore the potential benefits of H. pylori eradication on CAD risk and patient outcomes.

Main Methods:

• Systematic review and critical appraisal of published epidemiological studies and clinical research.
• Analysis of data investigating the correlation between H. pylori seropositivity and the incidence or prevalence of CAD.
• Examination of studies assessing the impact of H. pylori eradication therapies on cardiovascular risk factors and events.

Main Results:

• The current evidence suggests a correlation between H. pylori infection and an increased risk of atherosclerosis and coronary artery disease.
• However, the causal relationship remains debated, with confounding factors and the precise mechanisms of inflammation not fully elucidated.
• Limited data exists on the efficacy of H. pylori eradication in reducing CAD risk or improving clinical outcomes.

Conclusions:

• While H. pylori infection is associated with CAD, its role as a direct causative agent requires further robust investigation.
• The hypothesis that H. pylori eradication may mitigate CAD risk or improve patient prognosis is not yet conclusively supported by evidence.
• Further research, including well-designed intervention trials, is necessary to clarify the etiological role of H. pylori in CAD and the therapeutic implications of its eradication.